Stockreport

Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]

Vanda Pharmaceuticals Inc.  (VNDA) 
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm Check Earnings Report
PDF Fanapt ® approved for the acute treatment of bipolar I disorder; commercial launch expected in Q3 2024 Milsaperidone NDA for schizophrenia and bipolar disorder expect [Read more]